Summary of case results.
| Patient | No. RTX Cycles | Adverse Events | Clinical Efficacy/Response | Duration of Followup Available, mo | Comments |
|---|---|---|---|---|---|
| 1 | 1 | 0 | No | 18 | |
| 2 | 1 | 0 | No | 6 | |
| 3 | 3 | Uveitis | Yes | 24 | |
| 4 | 2 | Fever, PSO recurrence | No | 24 | |
| 5 | 1 | 0 | No | 24 | |
| 6 | 1 | Relapse of uveitis | No | 6 | Lost to followup |
| 7 | 1 | 0 | Yes | 14 | |
| 8 | 5 | 0 | Yes | 48 | |
| 9 | 1 | Rash | No | 18 | |
| 10 | 2 | 0 | Yes | 12 | |
| 11 | 1 | 0 | Yes | 4 | Lost to followup |
| 12 | 1 | Severe infection | Yes | 18 | Knee prosthesis infection after 7 mo, septicemia after 16 mo |
| 13 | 5 | Cardiac failure | No | 40 | PSO improvement by 50% |
| 14 | 1 | 0 | Not evaluable | 6 | |
| 15 | 1 | 0 | No | 18 | |
| 16 | 1 | 0 | Not evaluable | NA | Lost to followup |
| 17 | 1 | 0 | Not evaluable | NA | Lost to followup |
| 18 | 1 | 0 | Yes | 12 | |
| 19 | 1 | 0 | No | 30 | |
| 20 | 1 | Mediastinal adenomegaly after 2 yrs | Yes | 24 | |
| 21 | 1 | 0 | No | 18 | |
| 22 | 1 | 0 | No | 9 | |
| 23 | 2 | PSO exacerbation | Yes | 26 | |
| 24 | 1 | 0 | Yes | 4 | |
| 25 | 2 | 0 | Yes | 10 | |
| 26 | 1 | 0 | No | 24 |
RTX: rituximab; PSO: psoriasis; NA: not available.